OAM
CRL icon

Ostrum Asset Management’s Charles River Laboratories CRL Stock Holding History

Ostrum Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,870
Closed -$345K – 646
2024
Q4 		$345K Sell
1,870
-78
-4% -$15K 0.03% 441
2024
Q3 		$384K Buy
1,948
+24
+1% +$4.99K 0.03% 422
2024
Q2 		$397K Sell
1,924
-151
-7% -$34.2K 0.03% 423
2024
Q1 		$562K Hold
2,075
– – 0.04% 422
2023
Q4 		$491K Buy
2,075
+9
+0.4% +$1.77K 0.04% 410
2023
Q3 		$405K Sell
2,066
-14
-0.7% -$2.87K 0.04% 475
2023
Q2 		$437K Buy
2,080
+3
+0.1% +$597 0.04% 452
2023
Q1 		$419K Buy
+2,077
New +$471K 0.04% 453

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return